DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Materials
Author Program NEWCreate Narrative
ASH logo

Ashland Inc. Stock Price

NYSE:ASH Community·US$3.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ASH Share Price Performance

US$0
-51.80 (-100.00%)
​
US$80.18
Fair Value
US$0
-51.80 (-100.00%)
​
Price US$0
Thu, 13 Aug 26
Fair ValueUS$80.18
Share Pricen/a

ASH Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$80.18 13.9% undervalued intrinsic discount

ASH: Operational Recovery Will Drive Future Gains Despite Temporary Plant Impact

1users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$89.7 23.0% undervalued intrinsic discount

Environmental And Urban Trends Will Widen Specialty Chemical Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$70 1.3% undervalued intrinsic discount

China Overcapacity And Tightening Environmental Rules Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
ASH logo
Ashland
1.3% undervalued intrinsic discount

China Overcapacity And Tightening Environmental Rules Will Squeeze Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 3 Sep
Read Narrative
ASH logo
Ashland
13.9% undervalued intrinsic discount

ASH: Operational Recovery Will Drive Future Gains Despite Temporary Plant Impact

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 13 Aug
Read Narrative
ASH logo
Ashland
23.0% undervalued intrinsic discount

Environmental And Urban Trends Will Widen Specialty Chemical Markets

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 1 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
ASH logo

ASH: Oral Biologics Push And Dividend Outlook Will Shape Future Returns

Fair Value: US$70 1.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
ASH logo

ASH: Activist Engagement And Q2 Execution Will Shape Fairly Valued Shares

Fair Value: US$80.18 13.9% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
ASH logo

ASH: Activist Sale Pressure And Cash Returns Will Drive Future Upside

Fair Value: US$89.7 23.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Moderate growth potential with acceptable track record.

2 Risks
3 Rewards
View Full Analysis

Ashland Inc. Key Details

US$1.8b

Revenue

US$1.2b

Cost of Revenue

US$615.0m

Gross Profit

US$540.0m

Other Expenses

US$75.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 04, 2026
1.64
33.39%
4.07%
73.5%
View Full Analysis

About ASH

Founded
1924
Employees
2900
CEO
Guillermo Novo
WebsiteView website
www.ashland.com

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

Recent ASH News & Updates

User avatar
Narrative Update • Sep 03

ASH: Oral Biologics Push And Dividend Outlook Will Shape Future Returns

Analysts have lifted their fair value estimate for Ashland from $51.07 to $70.00, citing updated assumptions on the discount rate, profit margin, revenue growth, and a higher future P/E multiple. What’s in the News for Ashland Ashland launched permexa sodium caprate, an intestinal permeation enhancer aimed at oral peptide and biologic drugs, including GLP 1 agonists, with strong pre launch engagement and positive feedback from pharmaceutical, biotech and CDMO customers.

Recent updates

No updates

Ashland Inc. Competitors

IP logo

International Paper

Symbol: NYSE:IP
Market cap: US$18.8b
BALL logo

Ball

Symbol: NYSE:BALL
Market cap: US$16.1b
ALB logo

Albemarle

Symbol: NYSE:ALB
Market cap: US$13.6b
AVY logo

Avery Dennison

Symbol: NYSE:AVY
Market cap: US$13.0b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide